Drug intelligence / Profile preview

qingchang wenzhong tablets

Development stage
Unknown
Lead developer
Yangtze River Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Qingchang Wenzhong tablets is a traditional Chinese medicine (TCM) candidate developed by Yangzijiang Pharmaceutical Group (specifically its subsidiary Jiangsu Longfengtang Traditional Chinese Medicine) for the treatment of moderately active ulcerative colitis (UC). The formulation is designed to treat UC patients presenting with TCM syndromes of mixed cold-heat and damp-heat with blood stasis obstruction. It is currently in Phase II clinical development in China, where it is being evaluated in a randomized, double-blind, dose-finding trial to assess its efficacy in achieving clinical remission and mucosal healing compared to standard active controls.

Other names
清肠温中片Qingchang Wenzhong Pian
02

Targets

AHR (Aryl hydrocarbon receptor)GUCY2C (Guanylate cyclase C receptor)

Beyond the preview

Go deeper on qingchang wenzhong tablets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on qingchang wenzhong tablets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call